생화학분자생물학회입니다.
Biomaterials-assisted spheroid engineering for regenerative therapy
작성자
Hye Sung Kim작성일자
2021-07-15조회수
576Name: Hye Sung Kim ( hskim1213@dankook.ac.kr ) | ||
2020-present | Research Assistant Professor, Institute of Tissue Regeneration Engineering, Dankook University | |
2016-2020 | Postdoctoral Research Fellow, Department of Biomedical Engineering, Columbia University, USA | |
2016-2016 | Senior Research Scientist, Institute of Bioscience & Bioengineering | |
2010-2015 | Ph.D., Department of Biomaterials Engineering, Kangwon National University |
Biomaterials-assisted spheroid engineering for regenerative therapy
Cell-based therapy is a promising approach in the field of regenerative medicine. As cells are formed into spheroids, their survival, functions, and engraftment in the transplanted site are significantly improved as compared to single cells transplantation. To improve the therapeutic effect of cell spheroids even further, various biomaterials (e.g. nano- or microparticles, fibers and hydrogels) have been developed for spheroid engineering. The biomaterials not only control overall spheroid formation (e.g. size, shape, aggregation speed, and degree of compaction), but also regulate cell-to-cell and cell-to-matrix interactions in spheroids. Therefore, cell spheroids in synergy with the biomaterials have recently emerged for cell-based regenerative therapy. Biomaterials-assisted spheroid engineering has been extensively studied for regeneration of bone or/and cartilage defects, critical limb ischemia and myocardial infarction. Furthermore, it has been expanding to pancreas islets and hair follicle transplantation. This mini review comprehensively reviews biomaterials-assisted spheroid engineering for regenerative therapy.
BMB Rep 2021 Jun 22;5359. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/34154700/